Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6703522

O=C(NC1CCNCC1)N(CCc1ccccc1)c1ccc(F)cc1F.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACKR3 P25106 3/20 0.42
▸ SIGMAR1 Q99720 2/20 0.39
▸ MLNR O43193 2/20 0.37
▸ DCUN1D1 Q96GG9 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ PPARG P37231 2/20 0.36
▸ PPARD Q03181 2/20 0.36
▸ PPARA Q07869 2/20 0.36
▸ SLC6A2 P23975 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ KLKB1 P03952 1/20 0.35
▸ PDK1 Q15118 1/20 0.35
▸ SMYD3 Q9H7B4 1/20 0.35
▸ CHRM5 P08912 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ CDK4 P11802 1/20 0.35
▸ CDK2 P24941 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6731864 0.76 PPARG (0.59) DCUN1D1POLBRAB9APPARGPPARD
Trifluoroacetic Acid SCHEMBL15565383 0.69 NPC1 (0.44) ACKR3POLBRAB9AKLKB1CHRM1
Trifluoroacetic Acid SCHEMBL5036144 0.69 CARM1 (0.47) SIGMAR1DCUN1D1SLC6A2SLC6A3
SCHEMBL6009189 0.67 EPHX2 (0.61) SIGMAR1EPHX2
Trifluoroacetic Acid SCHEMBL5040926 0.66 BCHE (0.47) SLC6A2SLC6A4SLC6A3
Trifluoroacetic Acid SCHEMBL19994597 0.65 ITGB3 (0.50) SLC6A2SLC6A4SLC6A3
Trifluoroacetic Acid SCHEMBL2953636 0.65 EPHX1 (0.65) RAB9AEPHX2
SCHEMBL9794587 0.64 MEN1 (0.47) POLBRAB9APPARGPPARA
Trifluoroacetic Acid SCHEMBL2426715 0.64 CACNA1B (0.44) MLNRDCUN1D1CDK4CDK2CDK5
SCHEMBL8023857 0.64 SIGMAR1 (0.64) SIGMAR1SMYD3CHRM1CHRM3EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006081-A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity ASTRAZENECA AB (SE) 2004-01-08 — — US disclosed
EP-1289957-A1 PHARMACEUTICALLY ACTIVE PIPERIDINE DERIVATIVES, IN PARTICULAR AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY AstraZeneca AB (SE) 2003-03-12 — — EP disclosed
WO-2001087839-A1 PHARMACEUTICALLY ACTIVE PIPERIDINE DERIVATIVES, IN PARTICULAR AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY ASTRAZENECA AB (SE) 2001-11-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006081-A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity CCR5, CCR2, CCR1 ACKR3 18/4885SIGMAR1 450/4885MLNR 1087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback